Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-020214
Filing Date
2014-05-19
Accepted
2014-05-19 17:16:47
Documents
1
Period of Report
2014-05-19

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP rrd409789.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP rrd409789.xml 3 2145
  Complete submission text file 0001181431-14-020214.txt   3845
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEKTAR THERAPEUTICS 455 MISSION BAY BLVD SOUTH SAN FRANCISCO CA 94158
Business Address
Gergel Ivan P. (Reporting) CIK: 0001328288 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24006 | Film No.: 14855545